🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT07268404
Recruiting Not applicable

Women's Hormonal and Metabolic Wellbeing Study

NCT07268404 · tracked via the Priya Life Science USA tracker
Sponsor
Daily Nouri
Phase
Not applicable
Started
2025-12-10
Last updated
2026-08-25

Condition(s) studied

Metabolic Health

Investigational drug(s) / intervention(s)

Probiotic Blend CapsulePlacebo

Probiotic Blend Capsule: Hormone Balance Probiotic Blend

Placebo: Placebo

Study summary

The goal of this clinical trial is to learn if Daily Nouri Hormone Balance Probiotic blend can improve metabolic, inflammatory, and symptom outcomes in women.

Participants will:

* Take the probiotic blend or placebo every day for 12 weeks
* Complete virtual assessments and report symptoms throughout the study

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
45 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Self-reported irregular menstrual cycles, defined as one or more of the following: * Cycle length typically \>35 days OR \<21 days * Fewer than 9 menstrual periods in the past year * Unpredictable cycle timing (varies by \>7 days month-to-month) * Irregular cycles present for ≥6 months * One or more of the following hormonal balance concerns: skin, unwanted hair growth, hair thinning, weight concerns) * Self-reported emotional symptoms that fluctuate with menstrual cycle, including: * Mood swings or irritability * Feelings of stress or tension * Low mood or feeling down * Difficulty with emotional regulation * Not currently using hormonal therapies, metformin, GLP-1 receptor agonists, or anti-androgens. * If taking supplements for menstrual/hormonal support: willing to discontinue for 2-week washout before baseline * Weight stable (+ 5 pounds) for the past 2 months, not planning to start a new diet, exercise program, or medications during study * Able to provide electronic informed consent. * Willing to complete online surveys and at-home DBS sample collection. * Negative home pregnancy test at baseline. * Access to a computer or smartphone and reliable internet connection.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Alethios, Inc. San Francisco California Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07268404 on ClinicalTrials.gov ↗ ← All trials in the USA